Falvo P, Gruener S, Orecchioni S, Pisati F, Talarico G, Mitola G
Cell Death Differ. 2025; .
PMID: 39870804
DOI: 10.1038/s41418-025-01447-1.
Yanai Y, Kosaka T, Mikami S, Arai M, Watanabe K, Takeda T
Prostate. 2024; 85(3):308-314.
PMID: 39580660
PMC: 11720370.
DOI: 10.1002/pros.24828.
Lin Y, Song Y, Xu Y, Wang C, Xu Y, Huang X
Front Oncol. 2023; 13:1250927.
PMID: 38090492
PMC: 10715059.
DOI: 10.3389/fonc.2023.1250927.
Paal K, Stranz B, Thurner E, Langsenlehner U, Renner W, Brunner T
Strahlenther Onkol. 2023; 200(3):208-218.
PMID: 37658924
PMC: 10876759.
DOI: 10.1007/s00066-023-02132-3.
Bouzan J, Nellas S, Stoilkov B, Willschrei P, Horstmann M
Int Urol Nephrol. 2023; 55(6):1441-1446.
PMID: 37067702
PMC: 10185629.
DOI: 10.1007/s11255-023-03594-1.
Analysis of Frailty Syndrome in Men with Metastatic Prostate Cancer: A Scoping Review.
Mafla-Espana M, Torregrosa M, Cauli O
J Pers Med. 2023; 13(2).
PMID: 36836553
PMC: 9964735.
DOI: 10.3390/jpm13020319.
A systemic review of taxanes and their side effects in metastatic breast cancer.
Lai J, Chao T, Liu C, Huang C, Tseng L
Front Oncol. 2022; 12:940239.
PMID: 36303832
PMC: 9592970.
DOI: 10.3389/fonc.2022.940239.
Prevalence of frailty syndrome in urological patients undergoing major elective surgical procedure due to malignancy.
Michalik C, Juszczak K, Stelmach A, Kenig J, Drewa T
Cent European J Urol. 2022; 75(1):52-58.
PMID: 35591961
PMC: 9074062.
DOI: 10.5173/ceju.2022.0021.
Irradiation of localized prostate cancer in the elderly: A systematic literature review.
Marotte D, Chand-Fouche M, Boulahssass R, Hannoun-Levi J
Clin Transl Radiat Oncol. 2022; 35:1-8.
PMID: 35492872
PMC: 9046879.
DOI: 10.1016/j.ctro.2022.04.006.
Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study.
Serrano A, Martinez Tapia C, De La Taille A, Mongiat-Artus P, Irani J, Bex A
Cancers (Basel). 2021; 13(18).
PMID: 34572921
PMC: 8468518.
DOI: 10.3390/cancers13184694.
Impact of prostate-specific antigen screening on tumor size in patients with prostate cancer in a super-aging district in Kyoto, Japan.
Matsugasumi T, Okihara K, Tsujimoto M, Sato O, Imura T, Yamada Y
Int J Clin Oncol. 2021; 26(12):2303-2309.
PMID: 34537890
DOI: 10.1007/s10147-021-02016-5.
Comparison of G8 and ISAR Screening Results in Geriatric Urology.
Bouzan J, Stoilkov B, Nellas S, Horstmann M
Medicines (Basel). 2021; 8(8).
PMID: 34436219
PMC: 8398154.
DOI: 10.3390/medicines8080040.
Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?.
Taha T, Tan W, ElShafei A, Aminsharifi A, Given R, Cher M
Curr Urol. 2021; 15(2):79-84.
PMID: 34168524
PMC: 8221007.
DOI: 10.1097/CU9.0000000000000015.
2020 Korean guidelines for the management of metastatic prostate cancer.
Kim I, Shin S, Kang B, Kang J, Kim D, Kim M
Korean J Intern Med. 2021; 36(3):491-514.
PMID: 33561334
PMC: 8137395.
DOI: 10.3904/kjim.2020.213.
Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D'Amico Intermediate-/High-Risk Prostate Cancer in Older Patients.
Couderc A, Nicolas E, Boissier R, Boucekine M, Bastide C, Badinand D
Cancers (Basel). 2021; 13(1).
PMID: 33383957
PMC: 7795189.
DOI: 10.3390/cancers13010075.
Is age an independent risk factor for perioperative mortality and morbidity after radical prostatectomy? Analysis of the American college of surgeons national surgical quality improvement program database.
Merhe A, Hout M, Heidar N, El-Asmar J, Jaafar R, Mailhac A
Arab J Urol. 2020; 18(2):72-77.
PMID: 33029410
PMC: 7473160.
DOI: 10.1080/2090598X.2020.1721165.
A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age.
Iwamoto H, Izumi K, Kadomoto S, Makino T, Naito R, Yaegashi H
Asian J Androl. 2020; 23(1):36-40.
PMID: 32769233
PMC: 7831834.
DOI: 10.4103/aja.aja_39_20.
Histopathology, pharmacotherapy, and predictors of prostatic malignancy in elderly male patients with raised prostate-specific antigen levels - A prospective study.
Mathaiyan D, Tripathi S, Raj J, Sivaramakrishna B
Urol Ann. 2020; 12(2):132-137.
PMID: 32565650
PMC: 7292440.
DOI: 10.4103/UA.UA_68_19.
Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry.
Bluethmann S, Wang M, Wasserman E, Chen C, Zaorsky N, Hohl R
Cancer Med. 2020; 9(10):3623-3633.
PMID: 32212232
PMC: 7221418.
DOI: 10.1002/cam4.3003.
Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients.
Cui P, Cong X, Gao F, Yin J, Niu Z, Zhao S
World J Clin Cases. 2020; 8(1):54-67.
PMID: 31970170
PMC: 6962083.
DOI: 10.12998/wjcc.v8.i1.54.